DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Neutrophilic dermatosis complicating lenalidomide therapy.

Author(s): Thieu KP, Rosenbach M, Xu X, Kist JM

Affiliation(s): Harvard Medical School, Boston, Massachusetts, USA.

Publication date & source: 2009-10, J Am Acad Dermatol., 61(4):709-10. Epub 2009 Jul 3.

Publication type: Case Reports

Lenalidomide, a derivative of thalidomide, is an immunomodulatory agent introduced in 2004 for the treatment of multiple myeloma in combination with dexamethasone. It is also indicated for the treatment of myelodysplastic syndrome and is currently under investigative use for metastatic melanoma. We present a case of neutrophilic dermatosis involving predominantly the lower extremities in a patient receiving lenalidomide therapy for multiple myeloma.

Page last updated: 2009-10-20

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017